We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,672 hedge funds and large institutions have $321B invested in Johnson & Johnson in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,619 increasing their positions, 1,536 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

45% more funds holding in top 10

Funds holding in top 10: 532773 (+241)

33% more call options, than puts

Call options by funds: $3.35B | Put options by funds: $2.52B

5% more repeat investments, than reductions

Existing positions increased: 1,619 | Existing positions reduced: 1,536

0.04% less ownership

Funds ownership: 69.15%69.11% (-0.04%)

0% less funds holding

Funds holding: 3,6773,672 (-5)

12% less capital invested

Capital invested by funds: $365B → $321B (-$44.1B)

Holders
3,672
Holders Change
-5
Holders Change %
-0.14%
% of All Funds
61.85%
Holding in Top 10
773
Holding in Top 10 Change
+241
Holding in Top 10 Change %
+45.3%
% of All Funds
13.02%
New
131
Increased
1,619
Reduced
1,536
Closed
88
Calls
$3.35B
Puts
$2.52B
Net Calls
+$833M
Net Calls Change
-$135M
Name Holding Trade Value Shares
Change
Change in
Stake
Northwestern Mutual Wealth Management
226
Northwestern Mutual Wealth Management
Wisconsin
$117M +$13.9M +77,803 +13%
UCFA
227
United Capital Financial Advisors
Texas
$115M +$2.45M +13,739 +2%
CS
228
Candriam SCA
Luxembourg
$114M -$41M -229,897 -26%
Pzena Investment Management
229
Pzena Investment Management
New York
$113M -$14.1M -79,352 -11%
SAM
230
Silvercrest Asset Management
New York
$113M +$3.18M +17,853 +3%
Luther King Capital Management (LKCM)
231
Luther King Capital Management (LKCM)
Texas
$111M -$370K -2,078 -0.3%
Qube Research & Technologies (QRT)
232
Qube Research & Technologies (QRT)
United Kingdom
$111M +$48.6M +272,937 +78%
CIC
233
Crawford Investment Counsel
Georgia
$110M -$5.38M -30,176 -5%
N
234
Natixis
France
$109M -$153M -858,591 -58%
PHS
235
PFM Health Sciences
California
$109M +$5.38M +30,181 +5%
MG
236
Markel Group
Virginia
$108M
JWBC
237
John W. Bristol & Co
New York
$105M -$3.51M -19,677 -3%
FAF
238
Första AP-fonden
Sweden
$103M +$1.82M +10,200 +2%
BGIM
239
Brandywine Global Investment Management
Pennsylvania
$103M -$330M -1,852,209 -76%
VanEck Associates
240
VanEck Associates
New York
$103M +$13.8M +77,489 +15%
PCA
241
Personal Capital Advisors
California
$101M +$1.62M +9,070 +2%
Comerica Bank
242
Comerica Bank
Texas
$101M -$2.94M -16,505 -3%
TWC
243
TD Waterhouse Canada
Ontario, Canada
$98.6M +$910K +5,109 +1%
GAM
244
Guinness Asset Management
United Kingdom
$98.3M +$9.12M +51,199 +10%
NPA
245
Nichols & Pratt Advisers
Massachusetts
$97.7M -$1.06M -5,927 -1%
GG
246
Gofen & Glossberg
Illinois
$97.4M -$1.69M -9,496 -2%
DADC
247
D.A. Davidson & Co
Montana
$96.2M +$1.27M +7,148 +1%
NONA
248
Ninety One North America
New York
$95.2M +$4.46M +25,045 +5%
SC
249
Saturna Capital
Washington
$94.7M +$61.8K +347 +0.1%
LGF
250
LGT Group Foundation
Liechtenstein
$94M -$5.96M -33,438 -6%

JNJ Hedge Fund Activity: Q2 2022 in Review

3,672 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2022, worth a combined $321B — down 12% from $365B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new JNJ positions and 88 closed out — a net gain of 43 holders — while 1,619 added to existing stakes and 1,536 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.12B. The largest seller was Arrowstreet Capital, cutting an estimated $1.18B.

  • 3,672 institutional investors held Johnson & Johnson (JNJ) as of Q2 2022, down from 3,677 in Q1 2022.
  • Funds reported $321B of Johnson & Johnson stock for Q2 2022, down 12% quarter-over-quarter.
  • 131 funds opened new Johnson & Johnson positions in Q2 2022 and 88 closed out, a net change of +43 holders.
  • The largest Johnson & Johnson buyer in Q2 2022 was Morgan Stanley, an estimated $2.12B added.
  • The largest Johnson & Johnson seller in Q2 2022 was Arrowstreet Capital, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2022.